TuHURA Biosciences, Inc.
HURA
$2.46
-$0.16-6.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | |||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | -- | -- | -- | ||
| Cost of Revenue | -- | -- | -- | ||
| Gross Profit | -- | -- | -- | ||
| SG&A Expenses | 139.54% | 128.47% | -28.65% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 52.35% | 114.23% | -18.22% | ||
| Operating Income | -52.35% | -114.23% | 18.22% | ||
| Income Before Tax | -37.63% | -123.55% | -22.86% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -37.63% | -123.55% | -22.86% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -37.63% | -123.55% | -22.86% | ||
| EBIT | -52.35% | -114.23% | 18.22% | ||
| EBITDA | -53.19% | -116.50% | 18.10% | ||
| EPS Basic | 61.39% | -259.64% | -- | ||
| Normalized Basic EPS | 61.38% | -261.22% | -- | ||
| EPS Diluted | 61.39% | -252.49% | -- | ||
| Normalized Diluted EPS | 61.38% | -261.22% | -- | ||
| Average Basic Shares Outstanding | 256.55% | -37.77% | -- | ||
| Average Diluted Shares Outstanding | 256.55% | -37.77% | -- | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||